Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Investigating immune responses to aerosol BCG challenge in healthy UK adults

A human challenge study to evaluate innate and adaptive immune responses to a controlled human infection with BCG administered by the intradermal or aerosol inhaled route in healthy, BCG-naïve, UK adult volunteers

Trial categories: Vaccines

Sponsoring organisation: University of Oxford

Tuberculosis Vaccine Trial (TB043)

A BCG challenge study in healthy adults to help develop TB vaccines.

If you are aged 18-50, in good health, and have never received the BCG vaccine, you may be eligible to participate.

The study involves 9-11 visits over a period of around 6 months.

Participants will be reimbursed for their time and travel from £705 to £750.

For more information please use the following link:

Tuberculosis Vaccine Trial (TB043)